CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

Although CVS Health has underperformed its industry peers over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

This was the stock's second consecutive day of losses.

So, even beyond CVS Health's poor financial results, the guidance cuts are contributing to the terrible stock market performance the healthcare giant has posted in recent years.

CVS Health exceeded Q4 sales estimates with $97.71B revenue. The company projects 2025 revenue above $134B and expects Medicare Advantage margins to improve.

CVS Health Gains Momentum After Q4 Performance, Analyst Upgrades Stock Vandana Singh Thu, Feb 13, 2025, 2:46 PM3 min read ...

So, even beyond CVS Health's poor financial results, the guidance cuts are contributing to the terrible stock market performance the healthcare giant has posted in recent years.

CVS Health Corp. closed 8.04% below its 52-week high of $72.51, which the company achieved on May 1st.

On Wednesday, CVS Health Corp (NYSE:CVS) reported fourth-quarter sales of $97.71 billion, beating the consensus of $97.19 billion. Total revenues increased 4.2%, driven by growth in the Health ...